Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
168 hedge funds and large institutions have $1.57B invested in Amedisys in 2016 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 67 reducing their positions, and 21 closing their positions.
52% more call options, than puts
Call options by funds: $3.14M | Put options by funds: $2.07M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
7% more capital invested
Capital invested by funds: $1.46B → $1.57B (+$108M)
0% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 21
1% less funds holding
Funds holding: 169 → 168 (-1)
12% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 67
Top Buyers
Top Sellers
| 1 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$24.2M |
| 2 |
GAM
Gotham Asset Management
New York
|
-$8.99M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$7.49M |
| 4 |
Bank of New York Mellon
New York
|
-$5.99M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.83M |
AMED Hedge Fund Activity: Q2 2016 in Review
168 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2016, worth a combined $1.57B — up 7.4% from $1.46B a quarter earlier.
Fund positioning in AMED was balanced in Q2 2016: 21 funds opened new positions, 21 closed out, 59 added to existing stakes and 67 trimmed.
The largest buyer was Wells Fargo, adding an estimated $79.1M. The largest seller was North Tide Capital, exiting entirely with an estimated $24.2M sold.
- 168 institutional investors held Amedisys (AMED) as of Q2 2016, down from 169 in Q1 2016.
- Funds reported $1.57B of Amedisys stock for Q2 2016, up 7.4% quarter-over-quarter.
- 21 funds opened new Amedisys positions in Q2 2016 and 21 closed out, a net change of 0 holders.
- The largest Amedisys buyer in Q2 2016 was Wells Fargo, an estimated $79.1M added.
- The largest Amedisys seller in Q2 2016 was North Tide Capital, an estimated $24.2M sold.
Based on aggregated 13F filings for Q2 2016.